News about Global Pharma

Cipla to Enter Weight Management Segment, Expands Focus on Oncology and CNS Therapies

Cipla is set to enter India’s growing weight management market as part of its broader strategy to expand across emerging therapeutic segments.

Global Pharma | 14/07/2025 | By Dineshwori |  255

Wockhardt Realigns US Operations to Focus on Innovative Portfolio, Exits Generic Pharma Segment

Wockhardt has announced a strategic realignment of its US operations, exiting the loss-making generics business to focus on its innovation-led priorities in novel antibiotics and biologics, marking a decisive shift toward building a differentiated, future-ready pharmaceutical enterprise.

Global Pharma | 11/07/2025 | By Mrinmoy Dey |  530

Novartis Signs Brain Delivery Deal With Sironax, Wraps pCPA Talks on Cosentyx Reimbursement

Novartis has signed an exclusive option agreement with Chinese biotech firm Sironax to potentially acquire its proprietary Brain Delivery Module (BDM) platform and concluded negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) on the public reimbursement of Cosentyx.

Global Pharma | 11/07/2025 | By Dineshwori |  322

Glenmark's IGI Signs Licensing Deal with AbbVie for Investigational Cancer Therapy

AbbVie to lead global development, manufacturing and commercialisation of Ichnos Glenmark Innovation’s (IGI) investigational cancer therapy ISB 2001 in North America, Europe, Japan, and Greater China, while Glenmark will take these roles in emerging markets.

Global Pharma | 11/07/2025 | By Dineshwori |  299

Celltrion Announces Three-Stage Strategy to Counter Trump's Pharma Tariff Plan

Celltrion has announced its response strategy to US President Donald Trump’s plan to impose tariffs on pharmaceuticals.

Global Pharma | 10/07/2025 | By Dineshwori |  518

MolecuLight Appoints Dr. Julia Wright, MD, FACP, as its New Chief Medical Officer

MolecuLight Inc. announced the appointment of Dr. Julia Wright, MD, FACP, as its new Chief Medical Officer (CMO). In this pivotal role, Dr. Wright will lead MolecuLight's global medical and clinical strategy.

Global Pharma | 10/07/2025 | By Manvi |  194

Sandoz Begins Construction Of USD 440 Million Biosimilars Production Facility In Slovenia

Sandoz is constructing a new facility in Slovenia to strengthen its European biosimilar hub and expand its global market presence.

Global Pharma | 10/07/2025 | By Dineshwori |  509

Centrient Pharmaceuticals Appoints New Site Director for Delft Facility

Centrient Pharmaceuticals has announced the appointment of Pierre-Yves Dalla-Libera as the new Site Director for its Delft facility, effective September 1, 2025.

Global Pharma | 10/07/2025 | By Dineshwori |  715

Merck to Acquire Verona Pharma for USD 10 Billion to Expand Cardio-Pulmonary Portfolio

Merck, through a subsidiary, will acquire Verona Pharma for USD 107 per American Depository Share (ADS), each of which represents eight shares of Verona Pharma, for a total transaction value of approximately USD 10 billion.

Global Pharma | 10/07/2025 | By Dineshwori |  475

Global API Market Expected to Reach USD 422.8 Billion by 2034

The global Active Pharmaceutical Ingredients (API) market is projected to grow at a compound annual growth rate (CAGR) of 6.7 percent to an estimated USD 422.8 billion by 2034, according to a report.

Global Pharma | 09/07/2025 | By Dineshwori |  222